New salvage treatment for AML/MDS after allogeneic transplant: the VIOLA trial

The outcome for patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) after allogeneic stem cell transplantation remains poor. In this interview, Charles Craddock, CBE, FRCP (U... Author: VJHemOnc Added: 12/18/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts